172 related articles for article (PubMed ID: 18056119)
1. Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy.
Purohit A; Fusi L; Brosens J; Woo LW; Potter BV; Reed MJ
Hum Reprod; 2008 Feb; 23(2):290-7. PubMed ID: 18056119
[TBL] [Abstract][Full Text] [Related]
2. Aromatase expression in endometriosis.
Noble LS; Simpson ER; Johns A; Bulun SE
J Clin Endocrinol Metab; 1996 Jan; 81(1):174-9. PubMed ID: 8550748
[TBL] [Abstract][Full Text] [Related]
3. Estrogen metabolizing enzymes in endometrium and endometriosis.
Dassen H; Punyadeera C; Kamps R; Delvoux B; Van Langendonckt A; Donnez J; Husen B; Thole H; Dunselman G; Groothuis P
Hum Reprod; 2007 Dec; 22(12):3148-58. PubMed ID: 17921479
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element.
Zeitoun K; Takayama K; Michael MD; Bulun SE
Mol Endocrinol; 1999 Feb; 13(2):239-53. PubMed ID: 9973254
[TBL] [Abstract][Full Text] [Related]
5. Effects of steroid hormone on estrogen sulfotransferase and on steroid sulfatase expression in endometriosis tissue and stromal cells.
Piccinato CA; Neme RM; Torres N; Sanches LR; Derogis PBMC; Brudniewski HF; Rosa E Silva JC; Ferriani RA
J Steroid Biochem Mol Biol; 2016 Apr; 158():117-126. PubMed ID: 26723541
[TBL] [Abstract][Full Text] [Related]
6. Steroid sulphatase inhibitors for breast cancer therapy.
Purohit A; Woo LW; Chander SK; Newman SP; Ireson C; Ho Y; Grasso A; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):423-32. PubMed ID: 14623540
[TBL] [Abstract][Full Text] [Related]
7. Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection.
Matsuzaki S; Canis M; Pouly JL; Déchelotte PJ; Mage G
Fertil Steril; 2006 Feb; 85(2):308-13. PubMed ID: 16595205
[TBL] [Abstract][Full Text] [Related]
8. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
9. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of steroid sulfatase activity in endometriotic implants by STX64 (667Coumate): a potential new therapy.
Fusi L; Purohit A; Brosens J; Woo LW; Potter BV; Reed MJ
ScientificWorldJournal; 2008 Dec; 8():1325-7. PubMed ID: 19112542
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.
Noble LS; Takayama K; Zeitoun KM; Putman JM; Johns DA; Hinshelwood MM; Agarwal VR; Zhao Y; Carr BR; Bulun SE
J Clin Endocrinol Metab; 1997 Feb; 82(2):600-6. PubMed ID: 9024261
[TBL] [Abstract][Full Text] [Related]
12. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis.
Velasco I; Rueda J; Acién P
Mol Hum Reprod; 2006 Jun; 12(6):377-81. PubMed ID: 16641167
[TBL] [Abstract][Full Text] [Related]
13. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis.
Bulun SE; Zeitoun K; Takayama K; Noble L; Michael D; Simpson E; Johns A; Putman M; Sasano H
Endocr Relat Cancer; 1999 Jun; 6(2):293-301. PubMed ID: 10731122
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor.
Stanway SJ; Purohit A; Woo LW; Sufi S; Vigushin D; Ward R; Wilson RH; Stanczyk FZ; Dobbs N; Kulinskaya E; Elliott M; Potter BV; Reed MJ; Coombes RC
Clin Cancer Res; 2006 Mar; 12(5):1585-92. PubMed ID: 16533785
[TBL] [Abstract][Full Text] [Related]
15. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol.
Zeitoun K; Takayama K; Sasano H; Suzuki T; Moghrabi N; Andersson S; Johns A; Meng L; Putman M; Carr B; Bulun SE
J Clin Endocrinol Metab; 1998 Dec; 83(12):4474-80. PubMed ID: 9851796
[TBL] [Abstract][Full Text] [Related]
16. Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis.
Hudelist G; Czerwenka K; Keckstein J; Haas C; Fink-Retter A; Gschwantler-Kaulich D; Kubista E; Singer CF
Reprod Sci; 2007 Dec; 14(8):798-805. PubMed ID: 18089598
[TBL] [Abstract][Full Text] [Related]
17. The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates.
Chander SK; Purohit A; Woo LW; Potter BV; Reed MJ
Biochem Biophys Res Commun; 2004 Sep; 322(1):217-22. PubMed ID: 15313194
[TBL] [Abstract][Full Text] [Related]
18. [Steroid sulfatase inhibitor].
Nakata T; Ishida H; Shiotsu Y
Nihon Rinsho; 2010 Jun; 68(6):1073-8. PubMed ID: 20535958
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo.
Ishida H; Nakata T; Sato N; Li PK; Kuwabara T; Akinaga S
Breast Cancer Res Treat; 2007 Aug; 104(2):211-9. PubMed ID: 17061037
[TBL] [Abstract][Full Text] [Related]
20. Steroid sulfatase: molecular biology, regulation, and inhibition.
Reed MJ; Purohit A; Woo LW; Newman SP; Potter BV
Endocr Rev; 2005 Apr; 26(2):171-202. PubMed ID: 15561802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
